No Data
No Data
Stocks Most Loved and Shunned by Hedge and Mutual Funds
Snowflake, JD.com And Temu Parent PDD Are Among Top 8 Large Cap Losers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today
5 Things You Need to Know About COVID, Flu and RSV Vaccines This Fall
The FDA Approved a New Covid Vaccine. Should You Get It? -- Update 2 -- WSJ
No Data
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.